SE0101317D0 - Protein cluster v - Google Patents

Protein cluster v

Info

Publication number
SE0101317D0
SE0101317D0 SE0101317A SE0101317A SE0101317D0 SE 0101317 D0 SE0101317 D0 SE 0101317D0 SE 0101317 A SE0101317 A SE 0101317A SE 0101317 A SE0101317 A SE 0101317A SE 0101317 D0 SE0101317 D0 SE 0101317D0
Authority
SE
Sweden
Prior art keywords
protein cluster
identification
diseases
useful
obesity
Prior art date
Application number
SE0101317A
Other languages
English (en)
Swedish (sv)
Inventor
Anneli Attersand
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0101317A priority Critical patent/SE0101317D0/xx
Publication of SE0101317D0 publication Critical patent/SE0101317D0/xx
Priority to EP02718767A priority patent/EP1377603A1/fr
Priority to NZ52768202A priority patent/NZ527682A/en
Priority to JP2002581476A priority patent/JP2005500020A/ja
Priority to CA002440846A priority patent/CA2440846A1/fr
Priority to PCT/SE2002/000730 priority patent/WO2002083721A1/fr
Priority to US10/121,757 priority patent/US6835556B2/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0101317A 2001-04-12 2001-04-12 Protein cluster v SE0101317D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0101317A SE0101317D0 (sv) 2001-04-12 2001-04-12 Protein cluster v
EP02718767A EP1377603A1 (fr) 2001-04-12 2002-04-12 Groupe de prot ines v
NZ52768202A NZ527682A (en) 2001-04-12 2002-04-12 Protein Cluster V
JP2002581476A JP2005500020A (ja) 2001-04-12 2002-04-12 タンパク質クラスターｖ
CA002440846A CA2440846A1 (fr) 2001-04-12 2002-04-12 Groupe de proteines v
PCT/SE2002/000730 WO2002083721A1 (fr) 2001-04-12 2002-04-12 Groupe de protéines v
US10/121,757 US6835556B2 (en) 2001-04-12 2002-04-12 Protein cluster V

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101317A SE0101317D0 (sv) 2001-04-12 2001-04-12 Protein cluster v

Publications (1)

Publication Number Publication Date
SE0101317D0 true SE0101317D0 (sv) 2001-04-12

Family

ID=20283777

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101317A SE0101317D0 (sv) 2001-04-12 2001-04-12 Protein cluster v

Country Status (6)

Country Link
EP (1) EP1377603A1 (fr)
JP (1) JP2005500020A (fr)
CA (1) CA2440846A1 (fr)
NZ (1) NZ527682A (fr)
SE (1) SE0101317D0 (fr)
WO (1) WO2002083721A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078961A1 (fr) * 1999-06-23 2000-12-28 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
JP4514952B2 (ja) * 1998-07-02 2010-07-28 カルジーン エルエルシー ジアシルグリセロールアシルトランスフェラーゼタンパク質

Also Published As

Publication number Publication date
WO2002083721A1 (fr) 2002-10-24
CA2440846A1 (fr) 2002-10-24
JP2005500020A (ja) 2005-01-06
EP1377603A1 (fr) 2004-01-07
NZ527682A (en) 2005-04-29

Similar Documents

Publication Publication Date Title
WO2003104270A3 (fr) Genes de la duduline 2, produits d'expression, modele animal non humain : utilisations dans les maladies hematologiques humaines
EA200601121A1 (ru) Мутеины фактора роста фибробластов 21
CY1114679T1 (el) Συνθεσεις για διαγνωση και θεραπεια ασθενειων που συνδυαζονται με παρεκκλινουσα εκφραση φουτρινων (r-σπονδινων)
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
WO2006046073A3 (fr) Proteine du type c1q
WO2004096856A3 (fr) Famille de proteines secretees
GB0300718D0 (en) Proteins
SE0101317D0 (sv) Protein cluster v
SE0004828D0 (sv) Protein cluster II
SE0004325D0 (sv) Protein cluster I
ATE490979T1 (de) Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
IL169256A0 (en) Metalloprotease proteins
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
WO2002070563A3 (fr) Domaine de liaison de ligand au recepteur hormonal nucleaire
ATE329027T1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2002033058A3 (fr) Proteases a cysteine
WO2004005346A8 (fr) Recepteur de l'hormone nucleaire
MXPA05012414A (es) Proteina secretada similar a tnf.
WO2004056863A8 (fr) Variante d'epissage
WO2002070560A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2004003011A3 (fr) Recepteur hormonal nucleaire
WO2002062845A3 (fr) Molecules d'adhesion
DE60330565D1 (de) Anti-fragilis Antikörper und dessen Verwendungen
WO2004087194A3 (fr) Utilisation d'un produit de proteine dg931 dans la prevention et le traitement du diabete et/ou de l'obesite et/ou du syndrome metabolique
MX2007001117A (es) Metodos para diagnosticar la enfermedad de alzheimer.